Search research articles
Contact Us
Filters
Showing results (131-140 of 149) with videos related to
Page
of 15
Sort By:
Chemical Science
|
August 2, 2024
A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements
James L Wood, Saikat Ghosh, Zachary H Houston, et al.
Nature Communications
|
June 2, 2021
Acoustic cavities in 2D heterostructures
Maxim K Zalalutdinov, Jeremy T Robinson, Jose J Fonseca, et al.
International Journal of Molecular Sciences
|
March 17, 2019
Innovative Therapeutic Strategies for Effective Treatment of Brain Metastases
Malcolm Lim, Simon Puttick, Zachary H Houston, et al.
Southern Medical Journal
|
March 13, 2003
Anxiety and depression in hospitalized patients in resistant organism isolation
Glenn Catalano, Sally H Houston, Maria C Catalano, et al.
ACS Nano
|
September 16, 2020
Controlling the Biological Fate of Micellar Nanoparticles: Balancing Stealth and Targeting
Amal J Sivaram, Andri Wardiana, Sheilajen Alcantara, et al.
Advanced Healthcare Materials
|
June 11, 2016
Overcoming Instability of Antibody-Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies
Christopher B Howard, Nicholas Fletcher, Zachary H Houston, et al.
Chemical Science
|
June 14, 2021
Targeted and modular architectural polymers employing bioorthogonal chemistry for quantitative therapeutic delivery
Gayathri R Ediriweera, Joshua D Simpson, Adrian V Fuchs, et al.
EJNMMI Research
|
May 9, 2020
Targeted beta therapy of prostate cancer with <sup>177</sup>Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1)
Mei-Chun Yeh, Brian W C Tse, Nicholas L Fletcher, et al.
Biomaterials Science
|
April 5, 2022
Synthesis, characterisation and evaluation of hyperbranched <i>N</i>-(2-hydroxypropyl) methacrylamides for transport and delivery in pancreatic cell lines <i>in vitro</i> and <i>in vivo</i>
Akosua B Anane-Adjei, Nicholas L Fletcher, Robert J Cavanagh, et al.
ACS Central Science
|
June 4, 2020
Understanding the Uptake of Nanomedicines at Different Stages of Brain Cancer Using a Modular Nanocarrier Platform and Precision Bispecific Antibodies
Zachary H Houston, Jens Bunt, Kok-Siong Chen, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 149) with videos related to
Sort By:
Page
of 15
Chemical Science
|
August 2, 2024
A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements
James L Wood, Saikat Ghosh, Zachary H Houston, et al.
Nature Communications
|
June 2, 2021
Acoustic cavities in 2D heterostructures
Maxim K Zalalutdinov, Jeremy T Robinson, Jose J Fonseca, et al.
International Journal of Molecular Sciences
|
March 17, 2019
Innovative Therapeutic Strategies for Effective Treatment of Brain Metastases
Malcolm Lim, Simon Puttick, Zachary H Houston, et al.
Southern Medical Journal
|
March 13, 2003
Anxiety and depression in hospitalized patients in resistant organism isolation
Glenn Catalano, Sally H Houston, Maria C Catalano, et al.
ACS Nano
|
September 16, 2020
Controlling the Biological Fate of Micellar Nanoparticles: Balancing Stealth and Targeting
Amal J Sivaram, Andri Wardiana, Sheilajen Alcantara, et al.
Advanced Healthcare Materials
|
June 11, 2016
Overcoming Instability of Antibody-Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies
Christopher B Howard, Nicholas Fletcher, Zachary H Houston, et al.
Chemical Science
|
June 14, 2021
Targeted and modular architectural polymers employing bioorthogonal chemistry for quantitative therapeutic delivery
Gayathri R Ediriweera, Joshua D Simpson, Adrian V Fuchs, et al.
EJNMMI Research
|
May 9, 2020
Targeted beta therapy of prostate cancer with <sup>177</sup>Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1)
Mei-Chun Yeh, Brian W C Tse, Nicholas L Fletcher, et al.
Biomaterials Science
|
April 5, 2022
Synthesis, characterisation and evaluation of hyperbranched <i>N</i>-(2-hydroxypropyl) methacrylamides for transport and delivery in pancreatic cell lines <i>in vitro</i> and <i>in vivo</i>
Akosua B Anane-Adjei, Nicholas L Fletcher, Robert J Cavanagh, et al.
ACS Central Science
|
June 4, 2020
Understanding the Uptake of Nanomedicines at Different Stages of Brain Cancer Using a Modular Nanocarrier Platform and Precision Bispecific Antibodies
Zachary H Houston, Jens Bunt, Kok-Siong Chen, et al.
Page
of 15